Log in to save to my catalogue

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results...

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71712866

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

About this item

Full title

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

Publisher

Berlin: Springer

Journal title

European journal of nuclear medicine and molecular imaging, 2002-06, Vol.29 (6), p.775-782

Language

English

Formats

Publication information

Publisher

Berlin: Springer

More information

Scope and Contents

Contents

Differentiated thyroid cancer is a malignant tumour that has a fairly good prognosis, with patients surviving for many years. Multimodal therapy with surgery, radioiodine therapy and TSH suppressive medication is of proven efficacy. However, loss of differentiation is observed in up to one-third of patients with differentiated thyroid cancer, paral...

Alternative Titles

Full title

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_71712866

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71712866

Other Identifiers

ISSN

1619-7070

E-ISSN

1619-7089

DOI

10.1007/s00259-001-0737-6

How to access this item